BioSpace News Archive

Business

Exelixis Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2022 and provided an update on progress toward achieving key corporate objectives, as well as commercial, clinical and pipeline development milestones.

November 1, 2022
·
20 min read
Pharm Country

atai Life Sciences to Participate in November Investor Events & Healthcare Conferences

atai Life Sciences N.V. will participate in the following investor events & healthcare conferences.

November 1, 2022
·
2 min read
Clinical Trial Investigative Site Network Market Size to Hit USD 12.77 BN by 2030

The global clinical trial investigative site network market was valued at USD 7.51 billion in 2021 and is expected to hit around USD 12.77 billion by 2030, growing at a CAGR of 6.08% from 2022 to 2030.

November 1, 2022
·
8 min read
BioCapital

Sysmex Inostics Exhibits at Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoenix Arizona

Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, will exhibit at the Association of Molecular Pathology 2022 Annual Meeting & Expo in Phoenix Arizona from November 3, 2022, through November 5, 2022.

November 1, 2022
·
4 min read
BioMidwest

AAOS Announces 2023 IDEA Grant Program™ Recipients

The American Academy of Orthopaedic Surgeons supports the importance of diversity, equity and access across the field of orthopaedics.

November 1, 2022
·
4 min read
Business

ixlayer Announces Formation of Advisory Board

ixlayer , the leading platform for health testing, announces today the formation of the ixlayer Health Testing Advisory Board.

November 1, 2022
·
4 min read
Biotech Bay

Bioelectronic Medicine Company Boomerang Medical Raises $15M in Series A Financing

Boomerang Medical, a women-led bioelectronic medicine company, today announced the closing of a $15 million Series A financing led by existing investor Arboretum Ventures and new investor Hatteras Venture Partners.

November 1, 2022
·
4 min read
Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease

Shockwave Medical, Inc. announced today that the final 1,373-patient cohort analysis from the Disrupt PAD III Observational Study (OS) again demonstrates consistent IVL outcomes in complex and challenging lesions across multiple peripheral vessel beds.

November 1, 2022
·
5 min read
Biotech Bay

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 01, 2022

Cytokinetics, Incorporated announced that on October 31, 2022 it granted stock options to purchase an aggregate of 202,500 shares of common stock to 20 new employees, whose employment commenced in October 2022, as a material inducement to their employment.

November 1, 2022
·
3 min read
Business

Aptose Reports Results for the Third Quarter 2022

Aptose Biosciences Inc. announced financial results for the three and nine-month periods ended September 30, 2022 and provided a corporate update.

November 1, 2022
·
17 min read